Skip to main content
. Author manuscript; available in PMC: 2020 Jan 6.
Published in final edited form as: Cancer Causes Control. 2017 Sep 1;28(10):1043–1051. doi: 10.1007/s10552-017-0953-4

Table 2.

Hazard ratios (HR) and 95% confidence intervals (CIs) for the association between endometrial cancer status and CVD mortality in the Iowa Women’s Health Study

Characteristic CVD Mortality
Overall model Deaths, n (%) a HR (95% CI) b
Endometrial cancer status
No (n=2,352) 413 (17.6) 1.0
Yes (n=552) 71 (12.9) 0.75 (0.56, 0.99) 
Sensitivity analyses
Cases restricted to low-grade endometrioid endometrial cancer
Endometrial cancer status
No (n=2,352) 413 (17.6) 1.0
Yes (n=389) 56 (14.4) 0.76 (0.55, 1.05) 
Cases restricted to localized stage cancer
Endometrial cancer status
No (n=2,352) 413 (17.6) 1.0
Yes (n=420) 59 (14.0)  0.75 (0.54, 1.02)
Restricted to women without prevalent CVD
Endometrial cancer status
No (n=2,021) 317 (15.7) 1.0
Yes (n=464) 56 (12.1) 0.78 (0.56, 1.09)
Restricted to never smokers
Endometrial cancer status
No (n=1,584) 266 (16.8) 1.0
Yes (n=403) 52 (12.9) 0.79 (0.55, 1.13)
Restricted to women with questionnaire data ≤5 years before the reference/diagnosis date
Endometrial cancer status
No (n=1,865) 342 (18.3) 1.0
Yes (n=447) 62 (13.9) 0.88 (0.59, 1.34)
a

row percentage

b

Adjusted for time between questionnaire completion and reference/diagnosis date, history of oral contraceptive use (never, ever), alcohol use (no, yes), diabetes (no, yes), hypertension (no, yes), prevalent CVD (no, yes), education (< high school, high school graduate, > high school), smoking status (never, former, current), and stratified by match set ID